Ropivacaine
Drug40 ml 0.375% ropivacaine was injected after Locating brachial plexus.
NCT Number: NCT02961361
Dexmedetomidine is an α-2 adrenoreceptor agonist and has been extensively used through intravenous infusion,in order to improved the quality of block in regional anesthesia. In this prospective, randomized study, the authors focus on the effect of dexmedetomidine mixed with ropivacaine in coracoid approach brachial plexus block.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Phase 4
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
40 ml 0.375% ropivacaine was injected after Locating brachial plexus.
40 ml 0.375% ropivacaine mixed with dexmedetomidine was injected after Locating brachial plexus.
Time frame: once per hour after surgery until 24 hours after surgery
effective analgesia time
Time frame: 5,10,15,20,25,30 min after injection
Time frame: 2,6,12,24hour after injection
The First Hospital of Qinhuangdao
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07728838
Arm Injuries, Shoulder and Upper Arm Injury
Houston, Texas, United States
View Trial DetailsNCT07707960
Arm Injuries, Shoulder and Upper Arm Injury
Houston, Texas, United States
View Trial DetailsNCT05328934
Amputation, Congenital, Amputation, Traumatic
Tempe, Arizona, United States
View Trial DetailsNCT05261425
Arm Injuries, Surgical Wound
Atlanta, Georgia, United States
View Trial Details